Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Recruiting
Observational Study
Psoriasis
Cardiovascular Diseases
Cardiovascular Risk Factor
Cardiovascular Pathology
Psoriasis Vulgaris
Psoriatic Nail
Psoriasis Face
Psoriasis Guttate
Psoriasis Gyrata
Psoriasis Diffusa
Psoriasis Palmaris
Psoriasis Annularis
Psoriasis Circinata
Psoriasis Plantaris
Psoriasis Universalis
Psoriasis Geographica
Left Ventricular Dysfunction
Myocardial Infarction
Myocardial Ischemia
Heart Failure
Stroke
Heart Diseases
Heart Failure, Systolic
Heart Failure, Diastolic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Herlev and Gentofte Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients 18 years or older with a diagnosis of psoriasis will be invited to participate
Exclusion Criteria:
* Patients not able to cooperate to the study
* Patients unable understand and sign informed consent
Contacts